Presence of anemia and poor prognostic factors in patients with endometrial carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3187-3190

  Wilairat, Wanitchar ^a   Benjapibal, Mongkol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anemia; Endometrial cancer; Prognostic factors

Indexed keywords

EID: 84873598432     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3187     Document Type: Article

References (36)

1. Achariyapota V, Benjapibal M, Chaopotong P (2010). Prevalence and incidence of anemia in Thai patients with gynecologic cancer. Asian Pacific J Cancer Prev, 11, 1229-33.
2. Alici S, Kaya S, Izmirli M, et al (2006). Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit, 12, 221-9.
3. Boogaerts M, Mittelman M, Vaupel P (2005). Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models. Oncology, 69, 22-30.
4. Bron D, Meuleman N, Mascaux C (2001). Biological basis of anemia. Semin Oncol, 28, 1-6.
5. Caro JJ, Salas M, Ward A, et al (2001). Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer, 91, 2214-21.
6. Di Maio M, Pisano C, Tambaro R, et al (2006). The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancer. Front Biosci, 11, 1585-90.
7. Dicato M (2003). Anemia in cancer: some pathophysiological aspects. Oncologist, 8, 19-21.
8. Dische S (1991). Radiotherapy and anaemia-the clinical experience. Radiother Oncol, 20, 35-40.
9. Eichbaum MH, Weiss LM, Bruckner T, et al (2009). Prognostic impact of hemoglobin levels before and during carboplatin/ taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer. Med Sci Monit, 15, 156-63.
10. Eisenhauer EA, Vermorken JB, van Glabbeke M (1997). Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients. Ann Oncol, 8, 963-8.
11. Ferlay J, Shin HR, Bray F, et al (2010). Cancer incidence and mortality worldwide; in GLOBOCAN 2008, version 1.2. IARC CancerBase No. 10. Lyon, France, IARC. Availble from: http://www.dep.iarc.fr/globocan/globocan.htm.
12. Gadducci A, Sartori E, Landoni F, et al (2005). Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/ platinum-based regimen: results of a multicenter retrospective Italian study. Gynecol Oncol, 98, 118-23.
13. Gucer F, Moser F, Tamussino K, et al (1998). Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol, 70, 210-4.
14. Graeber TG, Osmanian C, Jacks T, et al (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
15. Hockel M, Vaupel P (2001). Biological consequences of tumor hypoxia. Semin Oncol, 28, 36-41.
16. Hockel M, Schlenger K, Aral B, et al (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res, 56, 4509-15.
17. Knight K, Wade S, Balducci L (2004). Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med, 116, 11-26.
18. Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306.
19. Liang BC (1996). Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neurooncol, 29, 149-55.
20. Logsdon MD, Eifel PJ (1999). FIGO stage IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys, 43, 763-75.
21. Metindir J, Dilek GB (2009). Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. J Cancer Res Clin Oncol, 135, 125-9.
22. Munstedt K, Kovacic M, Zygmunt M, et al (2003). Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer. Int J Oncol, 23, 837-43.
23. Mercadante S, Gebbia V, Marrazzo A, et al (2000). Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev, 26, 303-11.
24. Mundt AJ, Connell PP, Campbell T, et al (1998). Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol, 71, 1511-5.
25. Obermair A, Petru E, Windbichler G, et al (2000). Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer. Oncol Rep, 7, 639-44.
26. Obermair A, Handisurya A, Kaider A, et al (1998). The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer, 83, 726-31.
27. Pongsanon K, Benjapibal M, Ruengkhachorn I (2011). Prognostic significance of hemoglobin levels in patients with primary epithelial ovarian carcinoma undergoing platinum-based chemotherapy. Asian Pacific J Cancer Prev, 12, 131-6.
28. Reynolds TY, Rockwell S, Glazer PM (1996). Genetic instability induced by the tumor microenvironment. Cancer Res, 56, 5754-7.
29. Seshadri T, Prince HM, Bell DR, et al (2005). The Australian cancer anaemia survey: a snapshot of anaemia in adult patients with cancer. Med J Aust, 182, 453-7.
30. Tas F, Eralp Y, Basaran M, et al (2002). Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol, 25, 371-9.
31. Tamussino KF, Gücer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40.
32. Thews O, Koenig R, Kelleher DK, et al (1998). Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer, 78, 752-6.
33. Van Belle SJ, Cocquyt V (2003). Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol Hematol, 47, 1-11.
34. Vaupel P, Mayer A, Briest S, et al (2003). Hockel M: Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res, 63, 7634-7.
35. Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23.
36. Young SD, Marshall RS, Hill RP (1988). Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA, 85, 9533-7.